TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report.

Gregory J Riely et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.